- 0.25 "

: Digoxin Kern Pharma 0.25 Mg. ?  »
|
-

PER OS

Tablets

Cardiac failure:Digoxin KERN PHARMA is indicated for the treatment of chronic cardiac failure where the principal cause is systolic dysfunction. The greatest therapeutic benefit is achieved in patients with ventricular dilatation.Digoxin KERN PHARMA is specifically indicated where cardiac failure is accompanied by atrial fibrilation.Supraventricular arrhythmias:Digoxin KERN PHARMA is indicated for the treatment of certain supraventricular arrhythmias, particularly atrial fibrillation and flutter, where its principal beneficial effect is to reduce the ventricular rate.

151 20 33918 00

Kern Pharma S.l, Spain

01/2014 - 12/2018

.
, .
.
/
Digoxin 0.25 MG
Blister pvc/aluminium 50 x TABLETS 36

*

*

 

.

 
" !
 

- !
:  »
278
,